SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001157523-05-001840
Filing Date
2005-02-24
Accepted
2005-02-24 10:11:39
Documents
2
Period of Report
2005-02-24
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 ANTIGENICS 8-K a4829726.txt 8-K 3306
2 EXHIBIT 99.1 PRESS RELEASE a4829726ex99.txt EX-99.1 11835
  Complete submission text file 0001157523-05-001840.txt   16912
Mailing Address 630 FIFTH AVENUE SUITE 2170 NEW YORK NY 10111
Business Address 630 FIFTH AVENUE SUITE 2170 NEW YORK NY 10111 2123324774
ANTIGENICS INC /DE/ (Filer) CIK: 0001098972 (see all company filings)

IRS No.: 061562417 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-29089 | Film No.: 05636045
SIC: 2836 Biological Products, (No Diagnostic Substances)